Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China
Journal Title: Traditional Medicine Research - Year 2019, Vol 4, Issue 5
Abstract
On July 1, 2019, the website of the National Health Commission of the People’s Republic of China issued the “Notice on printing and distributing the first batch of national key monitoring and rational drugs (chemicals and biological products)” (National Health Office Medical Letter [2019] No. 558) [1], where the third article stipulates: “Other types of physicians, after not less than one year of systematically studying Chinese medicine professional knowledge and passing the examination, in accordance with the basic principles of syndrome differentiation, can issue prescriptions for Chinese patent medicine”. This mandates that Western medicine doctors in China no longer prescribe Chinese patent medicines (CPM) without completing the required training. Before the implementation of this regulation, it was common for Western medicine doctors to prescribe CPM. The market for CPM is quite large [2]. Many traditional Chinese medicine (TCM) doctors believe that Western medicine doctors who have not received specific training in TCM run the risk of incorrectly prescribing CPM [3]. In fact, the vast majority of CPM are subject to the same evaluation criteria and assessment procedures as are chemical drugs. CPM are evaluated using modern medical evaluation systems, are evaluated after they are marketed, and are subjected to standardized clinical trials rather than to evaluation using the TCM theory. Patients experiencing toxic effects from the use of TCM are found to be genetically susceptible to the effects of certain herb ingredient. For example, a recent study found that the genetic basis for susceptibility to Heshouwu (Fallopia multiflora), resulting in liver damage, is the HLA-B*35:01 allele [4]. It is difficult for Western medicine doctors to identify which patients may be genetically susceptible to the toxic effects of Heshouwu (Fallopia multiflora). The method of syndrome differentiation based on TCM theory has also proven to be unsuccessful in identifying this susceptibility. In China, Chinese and Western medicine systems are equally important, and both are held in high regard [5]. As early as the 1950s, China organized various “Western Medicine Learning TCM” classes [6] and successfully trained a group of integrated medicine physicians. At the present time, 70% of CPM are prescribed by Western medicine doctors [7]. This above-mentioned regulation restricts Western medicine doctors from prescribing CPM that patients can purchase from pharmacies, and, furthermore, compels Western medicine doctors to gain knowledge in TCM. We question whether this will result in Western medicine doctors abandoning the use of CPM. Interestingly, the stock prices of CPM companies offered in the A-share market fell after these new regulations were announced.
Authors and Affiliations
Editor Group of Traditional Medicine Research
Keywords
Related Articles
- EP ID EP49631
- DOI 10.12032/TMR20190725126
- Views 266
- Downloads 0
The concept of vaccines first came from Chinese medicine
On July 15, 2018, the State Drug Administration of China issued a notice stating that the production records for freeze-dried human rabies vaccine manufactured by Changchun Changsheng Biotechnology Co., Ltd., could be fa...
South Asian medicinal plants and chronic kidney disease
Chronic kidney disease remains as one of the serious health issues in South Asia. The paucity of effective pharmacotherapy targeting the management of chronic kidney disease has led to a search for alternative pharmacolo...
Investigation of the processing technology and mechanism of Kansui radix by licorice based on response surface methodology and integrative pharmacology
Background: The herbs should be processed by different methods before use, and the efficacy and toxicity of Chinese herbal medicines may change, which may enhance efficacy and reduce toxicity after processing. Gansui (Ka...
The applications of Bayesian models in real-world studies of traditional Chinese medicine: a primer
Real-world study is valuable for traditional Chinese medicine. However, there are no gold standards of statistical approaches for analyzing data from real-world study of traditional Chinese medicine. With the development...
Errata Notice
On page 177, “确认是和 DNM 还是 DN 比较？” was a text comment written by an editor for fact checking purposes. It should have been removed before publishing. We deeply apologize to the readers and the authors of this...